Plasma Triglyceride Extraction by The Muscle
Regulation of the Plasma Triglyceride Extraction in Muscle in Insulin Resistance
Sponsor: American Diabetes Association
Listed as NCT01860911, this PHASE1 trial focuses on Insulin Resistance and Obesity and remains completed. Sponsored by American Diabetes Association, it has been updated 9 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Nov 2021 — Jul 2024 [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
-
Jan 2021 — Nov 2021 [monthly]
Active Not Recruiting PHASE1
-
Nov 2019 — Jan 2021 [monthly]
Active Not Recruiting PHASE1
▶ Show 4 earlier versions
-
Sep 2018 — Nov 2019 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Recruiting PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1
First recorded
Apr 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- American Diabetes Association
- Mayo Clinic
For direct contact, visit the study record on ClinicalTrials.gov .